Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1099834.RAWDWGMiC54FR7jfgiF3HbtfI2BTTy6cEezc-zdBpwp30130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1099834.RAWDWGMiC54FR7jfgiF3HbtfI2BTTy6cEezc-zdBpwp30130_assertion type Assertion NP1099834.RAWDWGMiC54FR7jfgiF3HbtfI2BTTy6cEezc-zdBpwp30130_head.
- NP1099834.RAWDWGMiC54FR7jfgiF3HbtfI2BTTy6cEezc-zdBpwp30130_assertion wasGeneratedBy ECO_0000203 NP1099834.RAWDWGMiC54FR7jfgiF3HbtfI2BTTy6cEezc-zdBpwp30130_provenance.
- NP1099834.RAWDWGMiC54FR7jfgiF3HbtfI2BTTy6cEezc-zdBpwp30130_assertion wasDerivedFrom befree-2016 NP1099834.RAWDWGMiC54FR7jfgiF3HbtfI2BTTy6cEezc-zdBpwp30130_provenance.
- NP1099834.RAWDWGMiC54FR7jfgiF3HbtfI2BTTy6cEezc-zdBpwp30130_assertion SIO_000772 23918607 NP1099834.RAWDWGMiC54FR7jfgiF3HbtfI2BTTy6cEezc-zdBpwp30130_provenance.
- NP1099834.RAWDWGMiC54FR7jfgiF3HbtfI2BTTy6cEezc-zdBpwp30130_assertion evidence source_evidence_literature NP1099834.RAWDWGMiC54FR7jfgiF3HbtfI2BTTy6cEezc-zdBpwp30130_provenance.
- NP1099834.RAWDWGMiC54FR7jfgiF3HbtfI2BTTy6cEezc-zdBpwp30130_assertion description "[Pretreatment biopsies from two cohorts of patients with intermediate-risk prostate cancer [T1/T2, Gleason score (GS) < 8, prostate-specific antigen (PSA) < 20 ng/mL; >7 years follow-up] were analyzed: (i) 126 patients [comparative genomic hybridization (CGH) cohort] with DNA samples assayed by array CGH (aCGH) for the TMPRSS2-ERG fusion; and (ii) 118 patients [immunohistochemical (IHC) cohort] whose biopsy samples were scored within a defined tissue microarray (TMA) immunostained for ERG overexpression (known surrogate for TMPRSS2-ERG fusion).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1099834.RAWDWGMiC54FR7jfgiF3HbtfI2BTTy6cEezc-zdBpwp30130_provenance.